Legacy insurer has named Mark Fleiser as managing director of its new Australian operation, following the acquisition of a local insurer and a legacy portfolio from Zurich.
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
The agreement reinforces cooperation in priority areas, including climate and energy security, Indo-Pacific infrastructure, and critical minerals to boost cross-border investments and exports in strategic...
Ralph Sherbahn leads MGA's Hong Kong business, which launches with AXA XL capacity and a focus on lines including cyber, D&O, and professional liability.
